Comparison of the results of different therapeutic measures in 198 myasthenia gravis patients.
Apostolski
S
S
Clinic for Neurology, School of Medicine, University of Belgrade, Yugoslavia.
Lavrnić
D
D
Djukić
P
P
Trikić
R
R
Gospavić
J
J
Dotlić
R
R
Pavlović
S
S
D000293:Adolescent; D000328:Adult; D000368:Aged; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D013934:Thymectomy
D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents